These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26176646)

  • 1. Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system.
    Spaniel F; Novak T; Bankovska Motlova L; Capkova J; Slovakova A; Trancik P; Matejka M; Höschl C
    J Psychiatr Ment Health Nurs; 2015 Dec; 22(10):811-20. PubMed ID: 26176646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study.
    Španiel F; Hrdlička J; Novák T; Kožený J; Höschl C; Mohr P; Motlová LB
    J Psychiatr Pract; 2012 Jul; 18(4):269-80. PubMed ID: 22805901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: a randomized controlled trial.
    Komatsu H; Sekine Y; Okamura N; Kanahara N; Okita K; Matsubara S; Hirata T; Komiyama T; Watanabe H; Minabe Y; Iyo M
    Schizophr Res; 2013 Oct; 150(1):240-4. PubMed ID: 23998952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITAREPS: information technology aided relapse prevention programme in schizophrenia.
    Spaniel F; Vohlídka P; Hrdlicka J; Kozený J; Novák T; Motlová L; Cermák J; Bednarík J; Novák D; Höschl C
    Schizophr Res; 2008 Jan; 98(1-3):312-7. PubMed ID: 17920245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up.
    Spaniel F; Vohlídka P; Kozený J; Novák T; Hrdlicka J; Motlová L; Cermák J; Höschl C
    Int J Clin Pract; 2008 Dec; 62(12):1943-6. PubMed ID: 18795967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
    Beasley CM; Sutton VK; Hamilton SH; Walker DJ; Dossenbach M; Taylor CC; Alaka KJ; Bykowski D; Tollefson GD;
    J Clin Psychopharmacol; 2003 Dec; 23(6):582-94. PubMed ID: 14624189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a systematic review of telephone delivered psychosocial interventions on relapse prevention, adherence to psychiatric medication and health risk behaviours in adults with a psychotic disorder.
    Beck AK; Baker A; Turner A; Haddock G; Kelly PJ; Berry K; Bucci S
    BMJ Open; 2015 Dec; 5(12):e009985. PubMed ID: 26700289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Education in schizophrenia: how patients and their relatives assess the relapse prevention programme PREDUKA].
    Motlová LB; Dragomirecká E; Matelová S; Otevrelová R; Cermáková R; Cermák J; Lednická E; Hegedüsová R; Hübsch T; Rothanzlová S; Tomesová M; Spaniel F; Kitzlerová E
    Cas Lek Cesk; 2010; 149(1):21-5. PubMed ID: 20662456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
    Csernansky JG; Mahmoud R; Brenner R;
    N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder.
    Fu DJ; Turkoz I; Simonson RB; Walling DP; Schooler NR; Lindenmayer JP; Canuso CM; Alphs L
    J Clin Psychiatry; 2015 Mar; 76(3):253-62. PubMed ID: 25562685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A program for relapse prevention in schizophrenia: a controlled study.
    Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
    Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia: A Randomized Clinical Trial.
    Berwaerts J; Liu Y; Gopal S; Nuamah I; Xu H; Savitz A; Coppola D; Schotte A; Remmerie B; Maruta N; Hough DW
    JAMA Psychiatry; 2015 Aug; 72(8):830-9. PubMed ID: 25820612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse prevention through health technology program reduces hospitalization in schizophrenia.
    Homan P; Schooler NR; Brunette MF; Rotondi A; Ben-Zeev D; Gottlieb JD; Mueser KT; Achtyes ED; Gingerich S; Marcy P; Meyer-Kalos P; Hauser M; John M; Robinson DG; Kane JM
    Psychol Med; 2023 Jul; 53(9):4114-4120. PubMed ID: 35634965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention in psychotic relapse.
    Birchwood M; Spencer E
    Clin Psychol Rev; 2001 Nov; 21(8):1211-26. PubMed ID: 11702513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
    Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia prediction with the adaboost algorithm.
    Hrdlicka J; Klema J
    Stud Health Technol Inform; 2011; 169():574-8. PubMed ID: 21893814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smartphone-Enhanced Symptom Management In Psychosis: Open, Randomized Controlled Trial.
    Lewis S; Ainsworth J; Sanders C; Stockton-Powdrell C; Machin M; Whelan P; Hopkins R; He Z; Applegate E; Drake R; Bamford C; Roberts C; Wykes T
    J Med Internet Res; 2020 Aug; 22(8):e17019. PubMed ID: 32788150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
    Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
    Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing Texting for Relapse Prevention: A Scalable mHealth Program for People With Schizophrenia and Schizoaffective Disorder.
    Ybarra ML; Rodriguez K; Madison H; Mojtabai R; Cullen BA
    J Nerv Ment Dis; 2019 Oct; 207(10):854-862. PubMed ID: 31503175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.